Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis

Males develop faster and more severe hepatocellular carcinoma than females in krasV12 transgenic zebrafish

(2017) Yan Li et al.   Scientific Reports

Metformin Inhibits Hepatocellular Carcinoma in a Cirrhosis Model

(2014) D.K. DePeralta et al.   JOURNAL OF SURGICAL RESEARCH

Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling

(2014) Yuan Yang et al.   MOLECULAR CARCINOGENESIS

Circulating adiponectin levels and risk of type 2 diabetes in the Japanese

(2014) S Yamamoto et al.   Nutrition & Diabetes

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

(2013) Bryan C. Fuchs et al.   HEPATOLOGY

NAFLD, NASH and liver cancer

(2013) Gregory A. Michelotti et al.   Nature Reviews Gastroenterology & Hepatology

Chemopreventive strategies in hepatocellular carcinoma

(2013) Siddharth Singh et al.   Nature Reviews Gastroenterology & Hepatology

8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer

(2010) H Sova et al.   BRITISH JOURNAL OF CANCER

Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro

(2010) Jun Yu et al.   HEPATOLOGY

Integrins as therapeutic targets: lessons and opportunities

(2010) Dermot Cox et al.   NATURE REVIEWS DRUG DISCOVERY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE